BioPharmSignal logoBioPharmSignal

Biotech News

HeartBeam Announces New Peer-Reviewed Article Demonstrating Potential to Help Identify Heart Attack Risk at Home

HeartBeam (BEAT)HeartBeamCompany update

BEAT (BEAT) appears in the live feed after a catalyst-style update. The headline is surfaced in real time so readers can move from signal to source without leaving the product flow.

The source domain is beat.com. BioPharmSignal keeps the ticker, timestamp, and source together for faster review before the wider market catches up.

The original release is available below in a new tab so readers can continue into the full source when needed.

Related news

BEATHeartBeam2026-10-05 12:31 EST

HeartBeam Receives FDA Breakthrough Device Designation for Heart Attack Assessment

BEATHeartBeam2026-06-30 11:00 EST

HeartBeam Completes Enrollment in Heart Attack Detection Pilot Study Ahead of Schedule

View all latest news

HeartBeam

Ambulatory Cardiac Diagnostics HeartBeam develops portable electrocardiogram technology intended to detect and monitor cardiac conditions outside traditional clinical settings. Cardiac Electrical Biomarker Platform The company reconstructs three-dimensional cardiac electrical information from a compact consumer-oriented device and...

Recent company news

BEATHeartBeam2026-10-05 12:31 EST

HeartBeam Receives FDA Breakthrough Device Designation for Heart Attack Assessment

BEATHeartBeam2026-09-21 12:31 EST

HeartBeam, Inc. Letter to Shareholders

BEATHeartBeam2026-08-13 20:01 EST

HeartBeam Reports Second Quarter 2026 Results

BEATHeartBeam2026-07-30 11:00 EST

HeartBeam to Host Second Quarter 2026 Results Conference Call on Thursday, August 13, 2026 at 4:30 p.m. Eastern Time

BEATHeartBeam2026-07-14 11:00 EST

HeartBeam Awarded New U.S. Patent Expanding Acoustic Sensing and Fluid Monitoring Capabilities of Its Cable-Free ECG Device

Stock data

Close
0.42 USD
Market cap
48.62M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States